Clinical Trials
5
Active:0
Completed:3
Trial Phases
2 Phases
Phase 2:3
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (60.0%)Phase 3
2 (40.0%)CPL-01 in the Management of Postoperative Pain After Bunionectomy
Phase 3
Recruiting
- Conditions
- Bunion
- Interventions
- Drug: Local anesthetic injection of CPL-01Drug: PlaceboDrug: Naropin, 0.5% Injectable Solution
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Cali Pharmaceuticals LLC
- Target Recruit Count
- 574
- Registration Number
- NCT05831449
- Locations
- 🇺🇸
Todd Bertoch, Salt Lake City, Utah, United States
Herniorrhaphy for Postoperative Pain
Phase 3
Recruiting
- Conditions
- Hernia, Inguinal
- Interventions
- Drug: local anaesthetic injection
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Cali Pharmaceuticals LLC
- Target Recruit Count
- 504
- Registration Number
- NCT05813847
- Locations
- 🇺🇸
Todd Bertoch, Salt Lake City, Utah, United States
Post-Operative Pain and Opioid Reduction Trial After Bunionectomy
Phase 2
Completed
- Conditions
- Hallux Valgus and Bunion
- Interventions
- Drug: Analgesic Non Narcotic
- First Posted Date
- 2022-06-09
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- Cali Pharmaceuticals LLC
- Target Recruit Count
- 73
- Registration Number
- NCT05411861
- Locations
- 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Trovare Clinical Research, Bakersfield, California, United States
🇺🇸Jean Brown Research, Salt Lake City, Utah, United States
A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy
Phase 2
Completed
- Conditions
- Inguinal Herniorrhaphy
- Interventions
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Cali Pharmaceuticals LLC
- Target Recruit Count
- 105
- Registration Number
- NCT05080959
- Locations
- 🇺🇸
Shoals Medical Trials, Inc, Sheffield, Alabama, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Anaheim Clinical Trials, Anaheim, California, United States
Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain
- First Posted Date
- 2019-12-02
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Cali Pharmaceuticals LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04182880
- Locations
- 🇺🇸
Chesapeake Research Group, Pasadena, Maryland, United States
News
No news found